Hydroxy Cal with Boron
Natural health product licensed in Canada
- Licence holder
- SISU
- NPN or DIN-HM
- 80005060
- Status
- Inactive licence
- Licence date
- 7 February 2008
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium | 125 mg | Not calculated |
| Boron | 0.5 mg | Not calculated |
| Manganèse | 1 mg | Not calculated |
| Vitamine C | 50 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 100 UI | Not calculated |
| Vitamine D Source : Cholécalciférol | 2.5 mcg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | Not specified |
Uses authorised in Canada
Helps in the normal development & maintenance of bones.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Avoid using within 2 hours prior to or until 4 hours after taking other medications. Consult a health care practitioner prior to use if you have chronic liver disease or impaired liver function. Consult a health care practitioner prior to use if you are taking tetracyclines. Some people may experience gastrointestinal disturbances such as diarrhea.
Source
Official Health Canada record, licence 80005060
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.